Senior Therapeutic Area Specialist: Cardiovascular Specialty, Royal Oak, MI at Bristol-Myers Squibb

Royal Oak, Michigan, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Field-based role requiring significant time spent with external customers (HCPs, RTLs, community-based physicians, office staff, stakeholders)
High level of scientific expertise in assigned products and therapeutic areas (Cardiovascular Specialty)
Ability to engage in deeper scientific dialogue consistent with label using approved resources
Proficiency with tools like SOPHIA for insights, territory/account planning, and dynamic call plans
Knowledge of emerging data for approved indications
Capability to organize external speaker programs and facilitate logistics using approved Speakers Bureau lists
Access to real-time medical support (e.g., Medical on Call) for complex inquiries

Responsibilities

Promote approved indications of BMS products within defined territory/region to meet/exceed sales targets compliantly
Create demand for BMS medicines by articulating clinical/scientific rationale for appropriate patients in a balanced manner
Build/maintain professional credibility with RTLs, community physicians/HCPs, private practices, medical groups, office staff, and stakeholders as primary contact
Prepare/implement comprehensive territory and account plans; proactively use tools like SOPHIA for insights and call planning; provide feedback for improvement
Demonstrate scientific expertise/passion in fair/balanced dialogue using approved resources; conduct in-office presentations (e.g., lunch and learns)
Organize external speaker programs, select from approved lists, and handle scheduling/logistics
Liaise with BMS functions (e.g., cross-functional field teams) to deliver superior Customer Experience (Cx) and meet HCP needs timely/scientifically
Prioritize safe/appropriate use of BMS products while focusing on business results, performance objectives, and BMS values
Gather/share relevant insights/information internally with stakeholders

Skills

Cardiovascular Medicine

HCP Engagement

Scientific Dialogue

Customer Experience

Thought Leader Engagement

Pharmaceutical Sales

BioPharma

Demand Generation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free